Herpangina

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Herpangina trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingNot Applicable

NCT06263439

Surveillance of HFMD in Pediatric Outpatients

The aims of this prospective multicentric study is to determine the types of enteroviruses (EVs) responsible for hand, foot and mouth disease (HFMD) or herpangi…

France3,000 participantsStarted 2023-06-20

Treatment: Throat/buccal swab sample

All recent trials (7 shown)

CompletedPhase 1/2

NCT06754384

Tolerability, Safety, and Immunogenicity of Tetravalent Inactivated Enterovirus Vaccine (Vero Cell).

The trial aims to assess the tolerability, safety, and immunogenicity of the tetravalent inactivated enterovirus vaccine in adults and children aged 6 months to…

China552 participantsStarted 2025-01-15

Treatment: Low-dose of tetravalent inactivated enterovirus vaccine (Vero cell), Medium-dose tetravalent inactivated enterovirus vaccine (Vero cell)

Active — Not RecruitingPhase 1/2

NCT06063057

Inactivated Bivalent Enterovirus Vaccine (Vero Cell) Phase I/II Clinical Trial

The Phase I clinical trial is divided into two parts. The first part uses an open-label design, while the second part uses a randomized, double-blind, and contr…

China744 participantsStarted 2023-09-20

Treatment:

Herpangina

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Surveillance of HFMD in Pediatric Outpatients

All recent trials (7 shown)

Tolerability, Safety, and Immunogenicity of Tetravalent Inactivated Enterovirus Vaccine (Vero Cell).

Inactivated Bivalent Enterovirus Vaccine (Vero Cell) Phase I/II Clinical Trial

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Surveillance of HFMD in Pediatric Outpatients

All recent trials (7 shown)

Tolerability, Safety, and Immunogenicity of Tetravalent Inactivated Enterovirus Vaccine (Vero Cell).

Inactivated Bivalent Enterovirus Vaccine (Vero Cell) Phase I/II Clinical Trial

Sucralfate to Improve Oral Intake in Children With Infectious Oral Ulcers: a Randomized, Double-blind, Placebo-Controlle…

Effect of Recombinant Human Interferon α-2b Spray on Herpangina

Neurodevelopment Outcomes Following Severe Hand Foot and Mouth Disease in Vietnam

A Clinical Trial to Assess the Efficacy and Safety of an Inactivated Vaccine (Vero Cell) Against EV71 in Chinese Childre…